WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Timbers rally to beat San Jose 4
Ecuador's former vice president taken to hospital after arrest
Comicomment: NATO at 75, what's next?
Mexico denounces Ecuador to ICJ for embassy raid
UNC interim chancellor backs AD Bubba Cunningham after trustee criticism, audit push
Profile: President of Suriname Chandrikapersad Santokhi
4 dead in Ecuador traffic accident
Comicomment: Who is behind the provocations in South China Sea
Wembanyama headlines France's preliminary roster for Paris Olympics basketball tournament
Emission capping in focus as scientists predict hotter 2024
PGA Championship begins at Valhalla with Rory McIlroy, Tiger Woods
First unit of Maerdang Hydropower Station connected to grid